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Abstract
 .  .Human monoamine M -form phenol sulfotransferase PST was PCR-cloned and transiently expressed in COS-7 cells.
The recombinant enzyme was demonstrated to display not only the previously reported sulfotransferase activity toward
dopamine, but also novel manganese-dependent Dopartyrosine sulfotransferase activities. These results imply a new
functional role of the human M-form PST in the homeostatic regulation of Dopa and tyrosine.
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Sulfation is a major pathway for the biotransforma-
tionrexcretion of xenobiotics and endogenous com-
pounds such as steroid hormones, catecholamines,
w xand bile acids 1–3 . As another example of the latter
 .group of compounds, free tyrosine-O-sulfate TyrS
w xwas first detected in human urine in 1954 4 . Follow-
ing a 40-year controversy over its mechanism of
generation, we have recently obtained conclusive evi-
dence for the occurrence of the sulfation of L-p-tyro-
w xsine in several mammalian cell lines 5,6 , as well as
w xthe rat liver 7 . Using HepO2 human hepatoma cells
as a model, we have further demonstrated the enzy-
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matic sulfation of Dopa and other tyrosine isomers
w x8 . The enzyme, designated the Dopartyrosine sulfo-
transferase, has recently been purified from the rat
liver and demonstrated, through cDNA cloning and
sequencing, to be distinct from other rat aryl sulfo-
w xtransferases previously identified 7 . In view of its
substrate specificity toward Dopa and tyrosine iso-
mers, the Dopartyrosine sulfotransferase has been
hypothesized to play a role in the homeostatic regula-
tion of catecholamine precursors, Dopa and tyrosine,
in vivo.
In contrast to the enzymatic properties character-
ized for the purified rat liver Dopartyrosine sulfo-
w xtransferase 7 , the Dopartyrosine sulfotransferase
activities detected in HepG2 cell extract, interest-
w xingly, were found to be manganese-dependent 8 .
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These findings raise the question whether the HepG2
Dopartyrosine sulfotransferase represents a novel en-
zyme, as in the case of the rat liver Dopartyrosine
w xsulfotransferase 7 , or is it in fact one of the previ-
 .ously identified human aryl phenol sulfotransferases
w xwhich include the ’P-form’ and ‘M-form’ PSTs 9,10 ,
w xdehydroepiandrosterone sulfotransferase 11 , and es-
w xtrogen sulfotransferase 12 . To find clues to answer-
ing this question, HepO2 cytosol was subjected to
DEAE Bio-Oel and hydroxylapatite column chro-
w xmatography 8 . The Dopartyrosine sulfotransferase
activities were found to co-elute closely with the
M-form PST. Furthermore, the Dopartyrosine sulfo-
transferase displayed properties similar to those of
the M-form PST in terms of thermostability and
w xsensitivity to 2,6-dichloro-4-nitrophenol 8 . These
findings prompted our interests in investigating
whether the M-form PST is in fact responsible for the
manganese-dependent Dopartyrosine sulfotrans-
ferase activities in HepG2 cells. We therefore decided
to PCR-clone the M-form PST, and characterize the
enzymatic activities of the recombinant enzyme ex-
pressed using the COS-7 cell system.
For use in the PCR-cloning of the M-form PST,
 Xsense 5 -ATGCGAATTCGTAGAAGACTCAGAA-
X.  XTTAGAAG-3 and anti sense 5 -CGTAGAAT-
X.TCGCCACTGTGCCTGACTCAA-3 primers, cor-
responding to residues y7 through y27 and residues
966 through 984 of the reported nucleotide sequence
w xof the cDNA encoding the M-form PST 13 , were
synthesized with EcoRI restriction sites incorporated
at the ends. Using these two primers, a PCR reaction
in a 100 jiI reaction mixture was carried out under
 .the action of Pfu DNA polymerase Stratagene , with
 .a HepG2 cDNA library ATCC 77400 as the tem-
plate. Amplification conditions were 10 cycles of 1
min at 948C, 2 min at 608 to 508C touch-down; 18C
.decreasercycle , and 3 min at 728C, plus 25 more
cycles of 1 min at 948C, 2 min at 508C, and 3 min at
728C. The final reaction mixture was applied onto a
0.7% agarose gel, separated by electrophoresis, and
visualized by ethidium bromide staining. A discrete
PCR product containing 1032 base pairs was de-
tected. The gel slice containing this PCR product was
excised from the gel, and the DNA was isolated by
spin filtration. After EcoRI digestion, the PCR prod-
uct was subcloned into the EcoRI site of pBluescript
 .II SK q . The insert was verified, by nucleotide
w xsequencing 14 , to encode a polypeptide with the
same amino acid sequence as that of the human liver
w xM-form PST previously reported 13 .
To express the PCR-cloned M-form PST for enzy-
matic characterization, the M-form PST cDNA insert
was excised from the pBluescript II by digestion with
Fig. 1. Enzymatic sulfation of dopamine and D-p-tyrosine cat-
w3 xalyzed by the recombinant M-form PST using PAP SS as the
sulfate donor. For the M-form PST assay, the reaction mixture,
with or without MnCl , contained in a 50 ml volume: 50 mM2
 .Hepes-NaOH pH 7.0 , 250 mM sucrose, 25 mM NaF, 1 mM
X w35 x  .5 -AMP, 14 mM PAP S 4.4 Cirmmol , and 50 mM dopamine.
For the Dopartyrosine sulfotransferase activity assay, the assay
mixture, with or without MnCl , contained in a 50 ml volume:2
 .50 mM Ampso-NaOH pH 8.75 , 250 mM sucrose, 25 mM NaF,
X w35 x  .1 mM 5 -AMP, 14 mM PAP S 4.4 Cirmmol , and 1 mM
D-p-tyrosine. The reaction was started by the addition of the
enzyme preparation, allowed to proceed for 30 min at 378C, and
terminated by heating at 1008C for 3 min. The heat-treated
reaction mixture, cleared of precipitates by centrifugation, was
w35 xsubjected to the analysis of the S sulfated product using a
two-dimensional thin-layer separation procedure previously de-
w xveloped 18 . The figure shows the autoradiographs taken from
the TLC plates used for the two-dimensional thin-layer analysis
of the reaction mixtures. Panels A and C correspond to reaction
mixtures containing, respectively, dopamine and D-p-tyrosine as
substrate. Panels B and D correspond to reaction mixtures con-
taining the same substrates plus 10 mM MnCl . The dashed line2
circles indicate the positions of carrier synthetic dopamine S or
D-p-TyrS detected by ninhydrin staining.
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Table 1
M-Form PST and Dopartyrosine sulfotransferase activities of the
recombinant M-form PST expressed in COS-7 cells
Plasmid used for M-form PST Dopartyrosine
transfection activity pmolr sulfotransferase
min per mg activity pmolr
a.protein min per mg
a.protein
None 1.05"0.06 0.08"0.01
pMSG.CMV 0.71"0.04 0.07"0.03
pMSG.CMV.M-PST 537.58"10.29 2.19"0.20
a Specific activities shown represent mean"S.D. derived from
three experiments. M-form PST and Dopartyrosine sulfotrans-
ferase activities were assayed using, respectively, dopamine and
D-p-tyrosine as substrates in the absence of MnCl .2
EcoRI and subcloned into a mammalian expression
vector, pMSG.CMV. pMSO.CMV.M-PST carrying
the M-form PST cDNA or pMSG.CMV alone as a
.control were then individually transfected into COS-7
SV40 transformed African green monkey kidney cells
 . ATCC CRL 1651 using the LipofectAMINE Life
.Technologies -mediated procedure. Incubation was
for 18 h at 378C in OPTI-MEM I Reduced Serum
Medium, according to the manufacturer’s instruc-
tions. The transfected cells were then incubated at
378C in DMEM containing 10% fetal bovine serum.
At the end of a 48-h incubation, the cells were
washed twice with phosphate-buffered saline, and
homogenized in buffer A containing 10 mM Tris-HCl
 .pH 7.4 , 250 mM sucrose, 10 mgrml aprotinin and
1 mM PMSF. Aliquots of the homogenates were
assayed for the M-form PST and Dopartyrosine
sulfotransferase activities of the recombinant enzyme
using, respectively, dopamine and D-p-tyrosine as
substrates and radioactive 3X-phosphoadenosine 5X-
w35 x  w35 x.phospho S sulfate PAP S as the sulfate donor.
As shown in Panel A of Fig. 1, radioactive
w35 x  w35 x.dopamine-O- S sulfate dopamine S was pro-
duced when the extract of COS-7 cells transfected
with the expression vector harboring the M-form PST
cDNA was used in the assay. The same extract was
shown to contain a low, yet significant, level of the
sulfotransferase activity catalyzing the sulfation of
 .D-p-tyrosine Panel C, Fig. 1 . Interestingly, in the
presence of 10 mM MnCl , a dramatic increase in2
the activity toward D-p-tyrosine was observed Panel
.D . In contrast, the activity toward dopamine ap-
peared not as much affected in the presence of MnCl2
 .Panel B, Fig. 1 . It is to be noted that, in our
w xprevious studies using HepG2 cell extracts 6,8 , we
had also observed a manganese-dependence of the
Dopartyrosine sulfotransferase activities. The effects
of manganese ions on the Dopartyrosine sulfotrans-
ferase activities of the recombinant M-form PST
were examined further as described below. The
Dopartyrosine sulfotransferase and M-form PST ac-
tivities were also determined for the extracts prepared
from un-transfected COS-7 cells or COS-7 cells
transfected with the expression vector alone. Quanti-
tative data obtained are compiled in Table 1. For the
extract prepared from either un-transfected cells or
cells transfected with the expression vector alone
 .pMSG.CMV , only low levels of endogenous activi-
Table 2
Effects of manganese on the M-form PST and Dopartyrosine sulfotransferase activities of the recombinant M-form PST expressed in
COS-7 cells
a .Substrate used Specific activity pmolrminrmg protein
Control EDTA MnCl MnCl qEDTA2 2
b bL-p-Tyrosine 0.69"0.09 N.D. 4.85"2.42 N.D.
D-p-Tyrosine 2.19"0.20 1.74"0.06 294.38"42.16 1.43"0.72
L-m-Tyrosine 3.11"0.30 1.82"0.04 10.70"2.62 2.06"0.20
D-m-Tyrosine 18.93"0.74 15.80"1.09 459.76"25.75 14.10"0.60
L-Dopa 94.17"1.55 81.47"0.96 25.15"0.62 93.75"6.43
D-Dopa 305.71"16.37 303.60"3.94 116.71"56.82 297.56q10.63
Dopamine 537.58"10.29 433.55"8.70 1447.89"90.82 1168.15"10.68
a Specific activities shown represent mean"S.D. derived from three experiments. Dopartyrosine sulfotransferase and M-form PST
activities were assayed under the conditions described in the Figure 1 legend. The concentration of MnCl or EDTA tested was 10 mM.2
b Not detected.
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ties were detected with either dopamine or D-p-tyro-
sine as substrate. For the extract prepared from COS-7
cells transfected with the expression vector harboring
 .the M-form PST cDNA pMSG.CMV.M-PST , there
was a marked increase in the sulfotransferase activity
with either dopamine or D-p-tyrosine as substrate.
The effects of manganese ions on the Dopartyro-
sine sulfotransferase activities of the recombinant
M-form PST were further investigated. Our previous
studies using HepG2 cell homogenates have shown
that optimal Dopartyrosine sulfotransferase activities
were observed at 10 mM concentration of MnCl2
w x5,8 . As shown in Table 2, in the presence of 10 mM
MnCl , a greater than 134-fold stimulation of the2
activity of the recombinant enzyme was observed
with D-p-tyrosine as substrate, followed by 24.3-fold
for D-m-tyrosine, 7.0-fold for L-p-tyrosine, and 3.4-
fold for L-m-tyrosine. For dopamine, a 2.7-fold stimu-
lation in the presence of 10 mM MnCl was ob-2
served. Interestingly, repeated assays showed that, in
contrast to our previous data showing a modest man-
ganese-stimulation of the sulfation of L- or D-Dopa
w x8 , a considerable decrease in the sulfation of these
two Dopa isomers in the presence of MnCl was2
found. It remains to be clarified whether the decrease
was due to the chemical environment of the trans-
fected COS-7 cell extract, resulting in the degradation
of Dopa andror its sulfated product. It is worthwhile
pointing out that, at the end of the reaction, black
precipitates were found to accumulate in the reaction
mixtures containing L- or D-Dopa, but not in those
containing tyrosine isomers. Incorporation of an
equimolar amount of EDTA in the assay mixture
abolished to a large extent the stimulatory effects of
MnCl on the tyrosine sulfation. These results showed2
clearly that, similar to the findings previously made
w xusing HepG2 cell extracts 8 , the recombinant M-
form PST displayed remarkable manganese-stimula-
tory sulfotransferase activities toward particularly the
D-form tyrosine isomers. The physiological relevance
of this manganese stimulation is currently unknown.
However, considering the previous reports on the
development of Parkinsonian symptoms in individu-
w xals afflicted with manganese poisoning 15,16 , it will
be interesting to investigate whether the M-form PST
 .  .is one of the target enzyme s affected by the
increased level of manganese in vivo. It is possible
that for those manganese-poisoned individuals, the
Dopartyrosine sulfotransferase activities associated
with the M-form PST might have been activated,
resulting in the excessive removal of tyrosine and
Dopa and, therefore, the lowering of the production
of dopamine and other catecholamines. Another in-
triguing issue is why do D-form tyrosine isomers also
serve as substrates for the M-form PST. In this
regard, recent studies have demonstrated, for exam-
ple, that tyrosine residues of the human lens protein
may gradually undergo racemization forming the D-
w xisomer during the aging process 17 . Since D-tyro-
sine can not be used for protein synthesis, it is likely
that sulfation may be used as a means for increasing
the water solubility and thereby facilitating the excre-
tion of D-p-tyrosine generated from the turnover of
D-tyrosine-containing proteins in vivo.
In conclusion, the results obtained in the present
study imply a new functional role of the human
M-form PST in the homeostatic regulation of cate-
cholamine precursors, Dopa and tyrosine. It is impor-
tant to point out that, in contrast to the M-form PST,
the recently discovered rat liver Dopartyrosine sulfo-
transferase catalyzes the sulfation of Dopa and tyro-
w xsine in a manganese-independent manner 7 . Further-
more, the deduced amino acid sequence of the rat
liver Dopartyrosine sulfotransferase cDNA displays
only 72.6r52.4% similarityridentity to the human
M-form PST. It remains to be clarified, therefore,
whether in human liver cells, there is a distinct
sulfotransferase, homologous to the rat liver
Dopartyrosine sulfotransferase, which is capable of
catalyzing the sulfation of Dopa and tyrosine in a
manganese-independent manner.
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